Showing 1 - 10 results of 10 for search 'Jeffrey J Swigris', query time: 0.05s Refine Results
  1. 1
    Doença pulmonar intersticial relacionada a miosite e a síndrome antissintetase Myositis-related interstitial lung disease and antisynthetase syndrome

    Doença pulmonar intersticial relacionada a miosite e a síndrome antissintetase Myositis-related interstitial lung disease and antisynthetase syndrome by Joshua Solomon, Jeffrey J Swigris, Kevin K Brown

    Published 2011-02-01
    Get full text
    Article
  2. 2
    Is it time to include oxygen needs as an endpoint in clinical trials in patients with fibrosing interstitial lung disease? If so, how?

    Is it time to include oxygen needs as an endpoint in clinical trials in patients with fibrosing interstitial lung disease? If so, how? by Jeffrey J Swigris, Kerri Aronson, Susan S Jacobs, Dawn Repola

    Published 2023-12-01
    Get full text
    Article
  3. 3
    A first look at the reliability, validity and responsiveness of L-PF-35 dyspnea domain scores in fibrotic hypersensitivity pneumonitis

    A first look at the reliability, validity and responsiveness of L-PF-35 dyspnea domain scores in fibrotic hypersensitivity pneumonitis by Jeffrey J. Swigris, Kerri Aronson, Evans R. Fernández Pérez

    Published 2024-04-01
    Get full text
    Article
  4. 4
    Reliability and responsiveness of the D12 and validity of its scores as a measure of dyspnoea severity in patients with rheumatoid arthritis-related interstitial lung disease

    Reliability and responsiveness of the D12 and validity of its scores as a measure of dyspnoea severity in patients with rheumatoid arthritis-related interstitial lung disease by Jeffrey J Swigris, Sonye Danoff, Paul F Dellaripa, Joshua J Solomon, Tracy J Doyle

    Published 2023-11-01
    Get full text
    Article
  5. 5
    Reliability and validity of Chinese version of a tool to assess the quality of life in idiopathic pulmonary fibrosis in patients with interstitial lung disease

    Reliability and validity of Chinese version of a tool to assess the quality of life in idiopathic pulmonary fibrosis in patients with interstitial lung disease by Rui-Li Pan, Jeffrey J. Swigris, Yan-Wei Zhao, Ai-Min Guo, Qing Wu, Si-Jia Li

    Published 2019-01-01
    Get full text
    Article
  6. 6
    Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases

    Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases by Jeffrey J. Swigris, Kevin K. Brown, Rayid Abdulqawi, Ketan Buch, Daniel F. Dilling, Dirk Koschel, Krishna Thavarajah, Rade Tomic, Yoshikazu Inoue

    Published 2018-12-01
    Get full text
    Article
  7. 7
    Informal caregivers experience of supplemental oxygen in pulmonary fibrosis

    Informal caregivers experience of supplemental oxygen in pulmonary fibrosis by Bridget A. Graney, Frederick S. Wamboldt, Susan Baird, Tara Churney, Kaitlin Fier, Marjorie Korn, Mark McCormick, Thomas Vierzba, Jeffrey J. Swigris

    Published 2017-07-01
    Get full text
    Article
  8. 8
    Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort

    Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort by Vissagan Gopalakrishnan, Amanda M. Jones, Patricia Julien-Williams, Tania Machado, Robert L. Danner, Jeffrey J. Swigris, Robert Paine, Jay N. Lozier, Joel Moss

    Published 2018-03-01
    Get full text
    Article
  9. 9
    Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis

    Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis by Evans R. Fernández Pérez, James L. Crooks, Jeffrey J. Swigris, Joshua J. Solomon, Michael P. Mohning, Tristan J. Huie, Matthew Koslow, David A. Lynch, Steve D. Groshong, Kaitlin Fier

    Published 2021-06-01
    Get full text
    Article
  10. 10
    Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib

    Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib by Franck Rahaghi, John A Belperio, John Fitzgerald, Mridu Gulati, Robert Hallowell, Kristin B Highland, Tristan J Huie, Hyun J Kim, Martin Kolb, Joseph A Lasky, Brian D Southern, Jeffrey J Swigris, Joao A de Andrade

    Published 2021-03-01
    Get full text
    Article

Search Tools: